Advertisement

Topics

BioAxone BioSciences CEO Lisa McKerracher Accepts Role of Consortium Advisory Panelist for the Christopher Reeve Foundation

08:30 EDT 10 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
BioAxone BioSciences, Inc. , an emerging, clinical-stage biotechnology company focused on developing innovative drugs to treat spinal cord injury and restore neurological function, today announced that CEO Lisa McKerrache...

Other Sources for this Article

LaVoieHealthScience
Beth Kurth, 617-374-8800, ext. 106
bkurth@lavoiehealthscience.com

NEXT ARTICLE

More From BioPortfolio on "BioAxone BioSciences CEO Lisa McKerracher Accepts Role of Consortium Advisory Panelist for the Christopher Reeve Foundation"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...